share_log

Buy Definitive Healthcare Stock On Weakness, Analyst Says As Revised Outlook Appears Achievable

Buy Definitive Healthcare Stock On Weakness, Analyst Says As Revised Outlook Appears Achievable

分析師表示,由於修訂後的展望似乎是可以實現的,因此在疲軟的情況下買入權威醫療保健股
Benzinga ·  05/09 03:43

Tuesday, Definitive Healthcare Corp (NASDAQ:DH) reported first-quarter adjusted EPS of $0.08, up from $0.06 a year ago, in line with the consensus.

週二,Definitive Healthcare Corp(納斯達克股票代碼:DH)公佈的第一季度調整後每股收益爲0.08美元,高於去年同期的0.06美元,符合市場共識。

The company reported sales of $63.48 million, up 7%, missing the consensus of $63.99 million.

該公司報告的銷售額爲6,348萬美元,增長7%,未達到6,399萬美元的共識。

Adjusted EBITDA was $20 million, or 32% of revenue, compared to $15.7 million, or 26% of revenue in Q1 2023.

調整後的息稅折舊攤銷前利潤爲2,000萬美元,佔收入的32%,而2023年第一季度爲1,570萬美元,佔收入的26%。

In the first quarter, Definitive Healthcare grew its enterprise customer base by 30 or 6% Y/Y, ending with 559 enterprise customers.

在第一季度,Definitive Healthcare的企業客戶群增長了30%,同比增長了6%,最終增加了559家企業客戶。

Guidance: Definitive Healthcare sees second-quarter revenues of $62M– $63.5M versus a consensus of $65.19 million.

指導方針:Definitive Healthcare預計第二季度收入爲6200萬至6,350萬美元,而預期收入爲6,519萬美元。

The company forecasts second-quarter adjusted EPS of $0.08–$0.09 versus a consensus of $0.09.

該公司預計第二季度調整後的每股收益爲0.08美元至0.09美元,而市場普遍預期爲0.09美元。

Definitive Healthcare sees fiscal year 2024 revenues of $255M– $261M versus a consensus of $266.27 million.

Definitive Healthcare預計2024財年的收入爲2.55億美元至2.61億美元,而市場普遍預期爲2.6627億美元。

Definitive Healthcare anticipates 2024 adjusted EPS of $0.36–$0.38 versus a consensus of $0.38.

Definitive Healthcare預計2024年調整後的每股收益爲0.36美元至0.38美元,而市場普遍預期爲0.38美元。

William Blair notes that the management attributed the relative weakness to two primary factors:

威廉·布萊爾指出,管理層將相對疲軟歸因於兩個主要因素:

  • The broader macro environment continues to pressure the company's end markets, translating into tighter budgets and increased spending scrutiny.
  • Compounded by greater-than-expected disruption in sales activity following the organization's go-to-market restructuring actions taken earlier in the year.
  • The analyst notes that the company substantially restructured its salesforce to prioritize larger enterprise clients in core client verticals in January.
  • 更廣泛的宏觀環境繼續給公司的終端市場帶來壓力,轉化爲更緊縮的預算和更嚴格的支出審查。
  • 再加上該組織在今年早些時候採取市場重組行動後,銷售活動的中斷超過預期。
  • 分析師指出,該公司在1月份對銷售隊伍進行了實質性重組,以優先考慮核心客戶垂直領域的大型企業客戶。

In general, William Blair considers the recent quarter somewhat disappointing as it anticipated stronger indications of a rise in organic growth, particularly after management mentioned a slight improvement in retention trends towards the end of 2023 and the start of 2024.

總體而言,威廉·布萊爾認爲最近一個季度有些令人失望,因爲它預計有機增長有更強的跡象,尤其是在管理層提到到2023年底和2024年初留存率趨勢略有改善之後。

"We would be buyers on the weakness for two primary reasons," the analyst writes:

這位分析師寫道:“我們將成爲疲軟的買家,主要原因有兩個:

  • Management's revised guidance is reasonable despite a modest implied sequential revenue uptick in the second half of the year.
  • While the topline growth story remains depressed, the analyst remains positive on management's commitment to making select investments to support the platform while prioritizing profitability.
  • 儘管下半年收入連續略有增長,但管理層修訂後的指導方針還是合理的。
  • 儘管收入增長仍然低迷,但分析師對管理層承諾在優先考慮盈利能力的同時進行精選投資以支持該平台仍然持樂觀態度。

Price Action: DH shares are down 27.70% at $5.24 at last check Wednesday.

價格走勢:週三最後一次檢查時,DH股價下跌27.70%,至5.24美元。

譯文內容由第三人軟體翻譯。


以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
    搶先評論